Patent details

Basic Information

Publication number:

EP3867251

PCT Application Number:

US2019055091

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP197914294

PCT Publication Number:

WO2020081282

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

KRAS G12C INHIBITORS

French Title of Invention:

INHIBITEURS DE KRAS G12C

German Title of Invention:

KRAS-G12C-INHIBITOREN

SPC Number:

Dates

Filing date:

08/10/2019

Grant date:

07/09/2022

EP Publication Date:

25/08/2021

PCT Publication Date:

23/04/2020

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/09/2022

EP B1 Publication Date:

07/09/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/10/2022

Expiration date:

08/10/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/08/2022

 

 

Name:

Eli Lilly and Company

Address:

Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Inventor

1

Name:

COATES, David Andrew

Address:

United States (US)

2

Name:

BARDA, David Anthony

Address:

United States (US)

3

Name:

ZIA-EBRAHIMI, Mohammad Sadegh

Address:

United States (US)

4

Name:

LINDER, Ryan James

Address:

United States (US)

5

Name:

PENG, Sheng-Bin

Address:

United States (US)

Priority

Priority Number:

201862745502 P

Priority Date:

15/10/2018

Priority Country:

United States (US)

Classification

IPC classification:

C07D 417/14; A61P 35/00; A61K 31/517;

Publication

European Patent Bulletin

Issue number:

202236

Publication date:

07/09/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages